Veraflox (pradofloxacin) Oral Suspension for Cats

Veraflox® (pradofloxacin) Oral Suspension for Cats

Veraflox is a next-generation treatment for bacterial skin infections that targets two key enzymes necessary for bacterial DNA replication.*

An oral suspension syringe lies in front of a capped bottle of Veraflox.

Discover the Science of Veraflox

Veraflox was designed to improve upon the efficacy against Gram-positive and anaerobic pathogens versus previous-generation fluoroquinolones while delivering the same Gram-negative activity.*1

  • Green illustrated icon of four quadrants with arrows radiating from the center.
    High-affinity, dual molecular targeting of DNA gyrase and topoisomerase IV*²

  • Green illustrated icon of a medical chart overlayed with a check mark inside a circle.
    Extensive ocular safety testing³

  • Green illustrated icon of a cat’s face.
    Once-daily, easy-to-deliver administration

Show Cat Owners How Easy Veraflox Can Be

Dosing Volume/ Body Weight - 3.4mg/lb. (7.5mg/kg)
Frequency - Once daily for seven consecutive days
A pair of hands use a dispenser to pull Veraflox oral suspension from the product bottle.

Easy-to-use, low-mess dispenser makes accurate dosing easy

Convenient, once-daily dosing helps minimize the burden on owners

May be given with food

Pleasant vanilla taste

How Veraflox Works

Veraflox in Perspective

Veraflox is approved for the treatment of skin infections (wounds and abscesses) in cats. Pradofloxacin has favorable pharmacokinetics and demonstrates low MICs for many target pathogens.4

Ratio calculation extrapolated from FOI data. MIC90 used for pradofloxacin and marbofloxacin, orbifloxacin MIC obtained from original tablet study MIC range.
*The clinical significance of in vitro data has not been demonstrated.

Discover the efficacy, safety and ease-of-use of Veraflox.

To place an order, please contact your Elanco Sales Representative.



Veraflox is indicated for the treatment of skin infections (wounds and abcesses) in cats caused by susceptible strains of Pasteurella multocida, Streptococcus canis, Staphylococcus aureus, Staphylococcus felis and Staphylococcus pseudintermedius.


Federal law restricts this drug to use by or on the order of a licensed veterinarian. Federal law prohibits the extra-label use of this drug in food-producing animals. For use in cats only.

The use of fluoroquinolones in cats has been associated with the development of retinopathy and/or blindness. Such products should be used with caution in cats.


Do not use in Dogs. The use of fluoroquinolones in cats has been associated with the development of retinopathy and/or blindness. Such products should be used with caution in cats. The safety of pradofloxacin in cats younger than 12 weeks of age, used for breeding, or that are pregnant and/or lactating has not been evaluated. Quinolones should be used with caution in animals with known or suspected central nervous system (CNS) disorders. In such animals, quinolones have, in rare instances, been associated with CNS stimulation that may lead to convulsive seizures. The safety of pradofloxacin in immune-compromised cats (i.e., cats infected with feline leukemia virus and/or feline immunodeficiency virus) has not been evaluated. The administration of pradofloxacin for longer than 7 days induced reversible leukocyte, neutrophil and lymphocyte decreases in healthy, 12-week-old kittens.

About Elanco

Learn why we're a leading provider of innovative solutions that protect and enhance animal health.

Connect with Elanco

Veraflox, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. PM-US-22-1446

© 2023 Elanco or its affiliates.